In a previous study, we used an enzyme-linked immunosorbent assay to measure soluble human interleukin-2 receptors (IL3R), and found that when activated lymphocytes produce cell-associated IL-2R, they also release a soluble form of IL3R into culture supernatants in vitro. Soluble IL-2R have also bee
Elevated levels of the soluble form of bone marrow stromal cell antigen 1 in the sera of patients with severe rheumatoid arthritis
β Scribed by Byung Ok Lee; Katsuhiko Ishihara; Kakuro Denno; Yoshiko Kobune; Motoyuki Itoh; Osamu Muraoka; Tsuneyasu Kaisho; Takeshi Sasaki; Takahiro Ochi; Toshio Hirano
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 815 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
β¦ Synopsis
Objective. Bone marrow stromal cell antigen I (BST-1) is a novel glycosyl phosphatidylinositolanchored ectoenzyme, which is overexpressed on bone marrow stromal and synovial cell lines derived from patients with rheumatoid arthritis (RA). To investigate the pathophysiologic roles of BST-I in RA, we established an enzyme-linked immunosorbent assay (ELISA) system to detect the soluble form of BST-1 (sBST-1) and examined levels of sBST-1 in the sera of RA patients.
Methods. Concentrations of sBST-1 in sera from healthy donors and from patients with RA, osteoarthritis, Sjogren's syndrome, and systemic lupus erythematows were measured with the ELISA.
Results. In 7% of the RA patient samples (10 of 143), concentrations of serum sBST-1 were higher (-30-50-fold) than in non-RA samples. Serum sBST-1 concentrations showed no correlation with age, Creactive protein level, or rheumatoid factor level. All RA patients with high concentrations of serum sBST-1 had severe disease with involvement of several large joints.
Conclusion. We believe the measurement of serum sBST-I may have prognostic value, but further
π SIMILAR VOLUMES
CD137 (ILA/4-1BB) is a member of the tumor necrosis factor receptor family and regulates activation, proliferation and programmed cell death in T lymphocytes. Here we show the existence of a soluble form of CD137 (sCD137) of 16 kDa. sCD137 is released by activated lymphocytes, and in contrast to mem